Patrick A. Broderick - 01 Feb 2022 Form 4 Insider Report for Intersect ENT, Inc.

Role
EVP, GC & Corporate Secretary
Signature
/s/ Patrick A. Broderick
Issuer symbol
N/A
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4
Filing time
03 Feb 2022, 20:19:31 UTC
Previous filing
03 Dec 2021
Next filing
16 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XENT Common Stock Award $0 +25,895 +122% $0.000000 47,116 01 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the Vesting Commencement Date of February 1, 2022.
F2 Includes 41,999 Restricted stock units.